Cargando…
Bone disease in testicular and extragonadal germ cell tumours.
Of 297 patients with metastatic testicular and extragonadal germ cell tumours (GCT), bone involvement was detected clinically in 3% (7/251) of those at first presentation and in 9% (4/46) of relapsed cases. This difference was not statistically significant (95% confidence limits -2%; +14%). Concurre...
Autores principales: | Hitchins, R. N., Philip, P. A., Wignall, B., Newlands, E. S., Begent, R. H., Rustin, G. J., Bagshawe, K. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246879/ https://www.ncbi.nlm.nih.gov/pubmed/3224081 |
Ejemplares similares
-
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
por: Hitchins, R. N., et al.
Publicado: (1989) -
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989) -
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man.
por: Philip, P. A., et al.
Publicado: (1991) -
Chemotherapy of advanced malignant teratomas.
por: Newlands, E. S., et al.
Publicado: (1980) -
Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors?
por: Guindalini, Rodrigo Santa Cruz, et al.
Publicado: (2013)